Aethlon Story

<div class='circular--portrait' style='background:#006400;color: #FFE4E1;font-size:4em;'>AM</div>
AEMD -- USA Stock  

USD 2.64  0.06  2.22%

Aethlon Medical Average Equity is projected to increase significantly based on the last few years of reporting. The past year's Average Equity was at 4.21 Million. The current year Enterprise Value is expected to grow to about 13.4 M, whereas Earnings before Tax are forecasted to decline to (7.9 M). As some conservative investors are getting more into healthcare space, Aethlon Medical could be a your radar. We will evaluate why recent Aethlon Medical price moves suggest a bounce in February. In this post, I will also go over a few different drivers affecting Aethlon Medical's products and services, and explain how it may impact Aethlon Medical shareholders.
Published over two weeks ago
View all stories for Aethlon Medical | View All Stories
Reasons Aethlon Medical (NASDAQ:AEMD) can excite shareholders
We provide trade advice to complement the prevailing expert consensus on Aethlon Medical. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.

How important is Aethlon Medical's Liquidity

Aethlon Medical financial leverage refers to using borrowed capital as a funding source to finance Aethlon Medical ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Aethlon Medical financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Aethlon Medical's total debt and its cash.

How Aethlon utilizes its cash?

To perform a cash flow analysis of Aethlon Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Aethlon Medical is receiving and how much cash it distributes out in a given period. The Aethlon Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Aethlon Medical Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (4.68 Million)

An Additional Perspective On Aethlon Medical

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aethlon Medical has an asset utilization ratio of 65.21 percent. This indicates that the company is making $0.65 for each dollar of assets. An increasing asset utilization means that Aethlon Medical is more efficient with each dollar of assets it utilizes for everyday operations.
 2018 2019 2020 2021 (projected)
Current Assets4.04 M10.04 M11.55 M12.46 M
Total Assets4.12 M10.39 M11.95 M12.89 M

Our take on today Aethlon Medical surge

Latest downside deviation is at 4.55. Aethlon Medical is displaying above-average volatility over the selected time horizon. Investors should scrutinize Aethlon Medical independently to ensure intended market timing strategies are aligned with expectations about Aethlon Medical volatility.

Our Final Perspective on Aethlon Medical

When is the right time to buy or sell Aethlon Medical? Buying stocks such as Aethlon Medical isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily basis. With a relatively neutral outlook on the latest economy, it is better to hold off any trading of Aethlon as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Aethlon Medical.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Aethlon Medical. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to